Acneiform eruptions associated with vemurafenib - 09/02/13
Doi : 10.1016/j.jaad.2012.09.015
Tatyana A. Petukhova, AB a, Roberto A. Novoa, MD a, Kord Honda, MD a, Henry B. Koon, MD b, Meg R. Gerstenblith, MD a, ⁎ 
a Department of Dermatology, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
b Division of Hematology and Oncology, Department of Internal Medicine, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio
Correspondence to: Meg R. Gerstenblith, MD, Department of Dermatology, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Ave, Lakeside Third Floor, Cleveland, OH 44106| Supported by The Char and Chuck Fowler Family Foundation. |
|
| Disclosure: Dr Gerstenblith has received a grant from The Char and Chuck Fowler Family Foundation and The Skin Cancer Foundation Melissa K. Bambino Memorial Award. Dr Koon is on the Genentech Speakers Bureau and has participated in Genentech Advisory Boards. Ms Petukhova, Dr Novoa, and Dr Honda have no conflicts of interest to declare. |
© 2012
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 68 - N° 3
P. e97-e99 - mars 2013 Retour au numéro
Article précédent
- Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita
- Lars Komorowski, Ralf Müller, Artem Vorobyev, Christian Probst, Andreas Recke, Marcel F. Jonkman, Takashi Hashimoto, Soo-Chan Kim, Richard Groves, Ralf J. Ludwig, Detlef Zillikens, Winfried Stöcker, Enno Schmidt
- CD30+ reversible lymphoid dyscrasia (pseudolymphoma) following HIDA scintigraphy and the [Ring1]-[Ring2]-[C=O] generalized structure hypothesis
- Ryan K. Rader, William V. Stoecker, Kristen A. Hinton, Janine C. Malone, Thomas P. Schuman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?